SurModics

$53.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.47 (+0.89%) As of 8:53 PM UTC today

Why Robinhood?

You can buy or sell SurModics and other stocks, options, and ETFs commission-free!

About SRDX

SurModics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The company operates through the following segments: Medical Device and In Vitro Diagnostics. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN. The listed name for SRDX is Surmodics, Inc. Common Stock.

CEO
Gary R. Maharaj
Employees
370
Headquarters
Eden Prairie, Minnesota
Founded
1979
Market Cap
732.98M
Price-Earnings Ratio
1.07K
Dividend Yield
—
Average Volume
48.95K
High Today
$53.84
Low Today
$51.75
Open Price
$52.57
Volume
33.11K
52 Week High
$54.92
52 Week Low
$22.06

SRDX Earnings

-$0.18
$0.00
$0.19
$0.37
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Apr 28, Pre-Market

You May Also Like

DFHT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure